| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/02/1993 | CA1314044C Imidazopyridine derivatives |
| 03/02/1993 | CA1314043C 1,4-diazepines |
| 03/02/1993 | CA1314042C Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents |
| 03/02/1993 | CA1314012C Process for the preparation of 2-arylpropionic acids |
| 03/01/1993 | CA2077098A1 Benzopyran derivatives |
| 03/01/1993 | CA2077063A1 "shape memory effect surgical needles" |
| 03/01/1993 | CA2076929A1 Substituted mandelic acid derivatives, processes for their preparation and their use in medicaments |
| 03/01/1993 | CA2073833A1 Substituted 1-phenyl-1-benzoylamino-5-aminopentanes, their preparation and use |
| 02/28/1993 | CA2076801A1 N-substituted aminomethanediphosphonic acids |
| 02/28/1993 | CA2076114A1 Antitussive and expectorant composition |
| 02/27/1993 | CA2075846A1 Cyclic alkylmethylsiloxanes for skin care |
| 02/27/1993 | CA2074061A1 Benzamide multidrug resistance reversing agents |
| 02/25/1993 | DE4224781A1 (alpha)-glycosylquercetine, verfahren zu ihrer herstellung und ihre verwendung (Alpha) -glycosylquercetine, processes for their preparation and their use |
| 02/25/1993 | DE4123615A1 Cosmetic tonic based on aminoacid(s) - for use with oil mixt. to renew facial skin and cure rosacea |
| 02/24/1993 | EP0528776A1 Pharmaceutical composition containing carbachol and other cholinergic substances |
| 02/24/1993 | EP0528762A1 N-acyl-N-heterocyclyl- or naphthyl-alkyl amino acids as angiotensin II antagonists |
| 02/24/1993 | EP0528749A1 Indole derivatives and their use |
| 02/24/1993 | EP0528734A1 Thiazolidin-2,4-dione derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/24/1993 | EP0528678A1 A pyrrolidylthiocarbapenem derivative |
| 02/24/1993 | EP0528661A2 HIV protease inhibitors with N-terminal polyether substituents |
| 02/24/1993 | EP0528633A1 Pyrimidinyl acetamides as elastase inhibitors |
| 02/24/1993 | EP0528615A1 Cribrostatins 1 and 2 |
| 02/24/1993 | EP0528587A1 Inhibiting osteoclast-mediated bone resorption using substituted phenyl derivatives |
| 02/24/1993 | EP0528586A1 Inhibiting osteoclast-mediated bone resorption using aminoalkyl-substituted phenyl derivatives |
| 02/24/1993 | EP0528532A1 Use of natamycin for the treatment and prevention of poultry mycosis |
| 02/24/1993 | EP0528515A2 HMG-CoA reductase inhibitors in the prevention of restenosis following coronary angioplasty |
| 02/24/1993 | EP0528495A1 Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
| 02/24/1993 | EP0528485A1 17Beta-acyl-3-androsta-3,5-dienes as testosterone 5alpha-reductase inhibitors |
| 02/24/1993 | EP0528468A1 Use of triclosan for the manufacture of a medicament for inhibiting cyclooxygenase |
| 02/24/1993 | EP0528452A1 Immunomycin enzymatic and/or microbial methylation products |
| 02/24/1993 | EP0528369A2 Cyclic imino derivatives, pharmaceutical compositions containing them and process for their preparation |
| 02/24/1993 | EP0528337A1 New thiazolylbenzofuran derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
| 02/24/1993 | EP0528242A2 Trifluoromethyl containing pseudopeptides |
| 02/24/1993 | EP0528172A1 (2-Alkyl-3-pyridyl)methylpiperazine derivatives as PAF antagonists |
| 02/24/1993 | EP0528164A2 Use of xanthine derivatives for the manufacture of a medicament for the treatment of secondary nerve cell damages and function disorders after head-brain-traumata |
| 02/24/1993 | EP0528146A1 N-phenylthiourea derivatives and pharmaceutical use thereof |
| 02/24/1993 | EP0528135A1 Uses of 9,12,15-octadecatrien-6-ynoic acid |
| 02/24/1993 | EP0528076A1 Use of Mebeverine against non-specific inflammatory bowel disease |
| 02/24/1993 | EP0528026A1 New meso-azacyclic aromatic acid amides and esters as novel serotonergic agents |
| 02/24/1993 | EP0528007A1 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF $g(b) CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 02/24/1993 | EP0527979A1 Pharmaceutical for treating viral diseases |
| 02/24/1993 | EP0527964A1 Tetrahydrobenzothienopyridines, processes for their preparation and their use as pharmaceuticals |
| 02/24/1993 | EP0527962A1 Method, compositions, and compounds for modulating brain excitability |
| 02/24/1993 | EP0527925A1 Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline |
| 02/24/1993 | EP0527917A1 Use of adenosine and adenosine derivatives for anesthesia |
| 02/24/1993 | EP0527906A1 Inhibition of influenza virus replication by oligonucleotides |
| 02/24/1993 | EP0527891A1 Biodegradable polyesters for sustained drug delivery. |
| 02/24/1993 | EP0527889A1 Quinolizinone type compounds |
| 02/24/1993 | EP0527869A1 Benzylimidazole derivatives as anxiolytic and nootropic agents |
| 02/24/1993 | EP0527851A1 1h-substituted-1,2,4-triazole compounds for treatment of cardiovascular disorders |
| 02/24/1993 | EP0527845A1 Use of nickel and bromide ions for treating psoriasis |
| 02/24/1993 | EP0527832A1 Anti-fungal bile acid derivatives |
| 02/24/1993 | EP0527830A1 Sustained/enhanced antipyretic response |
| 02/24/1993 | EP0527818A1 Oligonucleotide modulation of arachidonic acid metabolism |
| 02/24/1993 | EP0527817A1 Gamma-butyrolactol ether derivatives |
| 02/24/1993 | EP0527804A1 Gene therapy for cell proliferative diseases |
| 02/24/1993 | EP0527801A1 Thiophene sulfonamides useful as carbonic anydrase inhibitors |
| 02/24/1993 | EP0527736A1 Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs. |
| 02/24/1993 | EP0419535A4 Platinum-polymer complexes and their use as antitumor agents |
| 02/24/1993 | EP0237522B1 Pharmaceutically active derivatives of tryptophan and pharmaceutical compositions containing them |
| 02/24/1993 | CN1069286A Production of pradimicin antibiotics |
| 02/24/1993 | CN1069275A Process for preparing phosphino-hydrocarbon-group 8-metal complexes,antitumor composition containing these complexes |
| 02/24/1993 | CN1069271A Processes for preparing (1) benzopyrano (4,3-c)-pyrazoles compounds |
| 02/24/1993 | CN1069270A Heteraryloxy-beta-carboline, processes for its production and use in pharmaceutical agents |
| 02/24/1993 | CN1069265A Process for purification of hematoidin |
| 02/24/1993 | CN1069264A Butyric acid amides |
| 02/24/1993 | CN1069197A Medicine for treating tympanitis |
| 02/24/1993 | CN1069192A Growth promoter for sucking pig |
| 02/24/1993 | CN1069191A Pharmaceutical combination formulation |
| 02/24/1993 | CN1019929C Prepn. of flufenamic-acid beciberi lotion |
| 02/24/1993 | CA2076553A1 1,7-fused 2-(piperazinoalkyl) indole derivatives, processes and intermediates for their preparation, and pharmaceutical compositions containing them |
| 02/23/1993 | US5189226 Ortho-substituted benzaldehydes |
| 02/23/1993 | US5189212 Used in estrogen replacement therapy like menopause, osteoporosis therapy, prevention of excessive hair growth of body and infertility |
| 02/23/1993 | US5189211 Thromboxane A2 antagonists |
| 02/23/1993 | US5189179 Serotonin 5ht1a agonists |
| 02/23/1993 | US5189178 Preventing protein destruction |
| 02/23/1993 | US5189157 Antibacterial cephalosporin compounds |
| 02/23/1993 | US5189150 Oasomycins |
| 02/23/1993 | US5189149 High concentration, solvent-free |
| 02/23/1993 | US5189066 Antiinflammatory agent |
| 02/23/1993 | US5189065 Administering the warm-blooded animals |
| 02/23/1993 | US5189064 Treatment of cocaine addiction |
| 02/23/1993 | US5189056 Decrease cell permeability; using sulfonates |
| 02/23/1993 | US5189055 Phenylpyrrolic compounds used as drugs, their preparation and application |
| 02/23/1993 | US5189051 Treatment of glaucoma and ocular hypertension with pyrrole angiotensin-II receptor antagonists |
| 02/23/1993 | US5189050 Fermentation analogs of virginiamycin m1 to treat panic and anxiety disorder |
| 02/23/1993 | US5189049 Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them |
| 02/23/1993 | US5189047 Useful in the treament of respiratory track disorder, hypertension and bronchodilator activity or utility as potassium channel activator |
| 02/23/1993 | US5189045 Antiserotonine agent |
| 02/23/1993 | US5189043 Isoquinolone derivatives, their production and use |
| 02/23/1993 | US5189042 Fluoromacrolides having immunosuppressive activity |
| 02/23/1993 | US5189041 Gastrointestinal and nervous system disorders, cardiovascular disorders, analgesics |
| 02/23/1993 | US5189038 Method of stimulating superoxide generation |
| 02/23/1993 | US5189037 Mixture of 8-hydroxy-2-(dipropylamino)-1,2,3,4-tetrahydro-naphthalene and 1-(2-pyrimidyl)pyrazine |
| 02/23/1993 | US5189036 Imidazolylbenzoyl substituted heterocycles |
| 02/23/1993 | US5189034 Vasodilating, antianginal agents |
| 02/23/1993 | US5189033 Analgesics, antiiflammatory agents |
| 02/23/1993 | US5189031 Urea derivatives, compositions and use |
| 02/23/1993 | US5189029 Destroying cancer tumors |
| 02/23/1993 | US5189026 Treatment of human diseases involving dysregulation or dysfunction of the nervous system |